MAUDE Adverse Event Report: SMITH & NEPHEW ORTHOPAEDICS LTD ACETABULAR CUP HAP 50MM WITH IMPACTOR; PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING

Catalog Number 74120150

Device Problem Biocompatibility (2886)

Patient Problems Pain (1994); Loss of Range of Motion (2032); Ambulation Difficulties (2544); Metal Related Pathology (4530)

Event Date 01/14/2020

Event Type  Injury  

Event Description

Us legal mdl.Bilateral patient.It was reported that, after a bhr resurfacing construct had been implanted on the plaintiff's right hip on (b)(6) 2007, the plaintiff experienced pain, elevated metal levels, metallosis, difficulty walking, lack of mobility, gait issues and back pain.A revision surgery was performed on (b)(6) 2020 to treat this adverse event.The plaintiff's outcome is unknown.

Manufacturer Narrative

H3, h6: it was reported that revision surgery of the right bhr hip implant was performed.As of today, the implanted devices all of which were used in the treatment, and additional information have been requested for this complaint but have not become available.Without definitive lot numbers, a complete complaint history review cannot be performed for the devices involved.As no device batch numbers were provided for investigation, a manufacturing record review and device labelling / ifu review could not be performed.All of the devices would have met manufacturing specifications.If more information is received, this investigation will be reopened.A risk management review was performed.No additional risks were identified as result of the reported event and no further actions are required at this time.Based on the reported symptoms it cannot be concluded that the events/clinical reactions (pain, elevated metal levels, metallosis, difficulty walking) were associated with a mal-performance of the implant.The patient impact cannot be determined at this time.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint.The investigation remains inconclusive and a definitive root cause cannot be determined.Additionally, specific factors known to contribute to the alleged fault cannot be provided due to the insufficient information.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.

Event Description

It was reported that, after a bhr tha construct had been implanted on the plaintiff's right hip on (b)(6) 2007, the plaintiff experienced pain, elevated metal levels, metallosis, difficulty walking, lack of mobility, gait issues and back pain.A revision surgery was performed on (b)(6) 2020 to treat this adverse event.During the revision, the cup and stem were well fixed and were left in place.The modular head was explanted and replaced with a biomet dual mobility system.The plaintiff's outcome is unknown.

Manufacturer Narrative

H10.Additional information in a2, a3, a4, b6, b7, d1, d2, d4, d10 and g4.H11.Corrected information in b5, d6a and d6b (the reported device was never explanted), h6 (health effect - clinical code & health effect - impact code).

Manufacturer Narrative

Section h3, h6: it was reported that a right hip revision surgery was performed due to pain, elevated metal levels, metallosis, difficulty walking, lack of mobility, gait issues and back pain.As of today, the implanted hemi head and sleeve, which were used in treatment have not been returned for evaluation.The cup used in treatment, remains implanted and therefore cannot be tested.A review of the historical complaints data for the devices concerned was performed using batch numbers, part numbers and the reported failure modes to evaluate patterns of repeated failures or defects.Similar complaints have been identified for the head.This will continue to be monitored via routine trending, however it should be noted that this device is no longer sold.In the absence of the actual devices, the production records were reviewed for the devices reportedly involved in this incident.All released devices involved met manufacturing specifications upon release for distribution.The review of the product ifu found adequate warnings and precautions in relation to the alleged failure modes.A risk management review was performed.The alleged failure modes and associated risks have been anticipated within the risk file and the anticipated risk level is still adequate.No further actions are required at this time.A review of historic escalation actions related to the products and similar complaint events was performed.Following the review, prior applicable escalation actions were identified and confirmed to reduce associated risks as far as possible.No further escalation actions are required.The available medical documents were reviewed.Although metallosis was reported, the revision operative report did not note any findings of metallosis.The clinical root cause of the reported pain, elevated metal ion levels, difficulty walking, lack of mobility and gait issues cannot be concluded.However, the patient¿s history of trochanteric bursitis, rheumatoid arthritis, and morbid obesity cannot be ruled out as contributing factors to the reported clinical symptoms and subsequent revision.It cannot be concluded that the reported events are associated with a malperformance of the implant or implant failure.The impact to the patient beyond the revision cannot be determined.Based on the information provided, further investigation of the reported complaint cannot be carried out and remains inconclusive.A definitive root cause cannot be determined.Specific factors known to contribute to the alleged fault are excessive physical activity levels, unreasonable stress on replacement system, excessive patient weight, trauma to the joint replacement, loosening of components may increase production of wear particles and accelerate damage to the bone.Should the devices or additional information be received, the complaint will be reopened.Based on this investigation, the need for corrective and preventative actions is not indicated.

• Brand Name: ACETABULAR CUP HAP 50MM WITH IMPACTOR
• Type of Device: PROSTHESIS, HIP, SEMI-CONSTRAINED, METAL/METAL, RESURFACING
• Manufacturer (Section D): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer (Section G): SMITH & NEPHEW ORTHOPAEDICS LTD; aurora house, spa park; leamington spa warwickshire CV31 3HL; UK CV31 3HL
• Manufacturer Contact: holly topping ; 7000 west william cannon drive; austin, TX 78735 ; 5123913905
• MDR Report Key: 12411008
• MDR Text Key: 269528175
• Report Number: 3005975929-2021-00394
• Device Sequence Number: 1
• Product Code: NXT
• UDI-Device Identifier: 03596010502568
• UDI-Public: 3596010502568
• Combination Product (y/n): N
• Reporter Country Code: US
• PMA/PMN Number: P040033
• Number of Events Reported: 1
• Summary Report (Y/N): N
• Report Source: Manufacturer
• Source Type: Foreign,Company Representative
• Reporter Occupation: Other
• Remedial Action: Recall
• Type of Report: Initial,Followup,Followup,Followup
• Report Date: 09/11/2023

1 Device was Involved in the Event

1 Patient was Involved in the Event

• Date FDA Received: 09/01/2021
• Is this an Adverse Event Report?: Yes
• Is this a Product Problem Report?: Yes
• Device Operator: Health Professional
• Device Catalogue Number: 74120150
• Device Lot Number: 64501
• Was Device Available for Evaluation?: No
• Is the Reporter a Health Professional?: No
• Date Manufacturer Received: 09/11/2023
• Was Device Evaluated by Manufacturer?: Device Not Returned to Manufacturer
• Is the Device Single Use?: Yes
• Is This a Reprocessed and Reused Single-Use Device?: No
• Type of Device Usage: Initial
• Removal/Correction Number: Z-2746-2015
• Patient Sequence Number: 1
• Treatment: 71309017 / LOT# 04JM01300A; 74222200 / LOT# 10063
• Patient Outcome(s): Hospitalization; Required Intervention
• Patient Age: 65 YR
• Patient Sex: Male
• Patient Weight: 153 KG